Michael Joyce, MD
Pulmonary Disease · Toms River, NJNPI 1780644005
Payments from drug & device makers
Across 379 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Boehringer Ingelheim$752
- Grifols USA, LLC$618
- Actelion Pharmaceuticals US, Inc.$450
- Genentech USA, Inc.$442
- plus $2K from 20 others
What the payments were for
- Food & beverage$7,109100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $1,551 |
| GSK | 79 | $1,169 |
| Boehringer Ingelheim | 44 | $752 |
| Grifols USA, LLC | 42 | $618 |
| Actelion Pharmaceuticals US, Inc. | 35 | $450 |
| Genentech USA, Inc. | 9 | $442 |
| Sunovion Pharmaceuticals Inc. | 23 | $293 |
| Mylan Specialty L.p. | 19 | $256 |
| Insmed, Inc. | 6 | $181 |
| Novartis | 9 | $181 |
| Sanofi | 6 | $172 |
| Mallinckrodt Hospital Products Inc. | 5 | $170 |
| Johnson & Johnson | 3 | $132 |
| Eisai Inc. | 1 | $120 |
| Stryker | 1 | $112 |
| Optinose US, Inc. | 1 | $93 |
| Philips North America LLC | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 6 | $78 |
| Exact Sciences | 3 | $68 |
| United Therapeutics Corporation | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Novo Nordisk | 2 | $29 |
| Medtronic | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$375
- XOLAIR$253
- FARXIGA$125
- ACTHAR$125
- OFEV$125
- Dayvigo$120
- Prolastin-C Liquid$114
- NEPTUNE$112
- DUPIXENT$112
- Prolastin-C$106
How this compares
$7,109 in reported general payments places this provider in the 70th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 11 | $9,371 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $2,158 |
| Atorvastatin Calcium | 160 | $1,307 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $1,087 |
| Rosuvastatin Calcium | 65 | $1,035 |
| Levothyroxine Sodium | 56 | $776 |
| Amlodipine Besylate | 74 | $553 |
| Olmesartan Medoxomil | 24 | $536 |
| Metoprolol Succinate | 34 | $503 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 35 | $478 |
| Metformin Hcl | 57 | $473 |
| Esomeprazole Magnesium | 14 | $423 |
| Nifedipine ErNifedipine | 13 | $422 |
| Lisinopril | 54 | $386 |
| Ezetimibe | 15 | $311 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Toms River
- Vinay SikandToms River$1.8M
- Muhammad KhanToms River$15K
- Reynold PanettieriNew Brunswick$2.5M
- Stanley FielMorristown$1.3M
- Joseph HoffmanPark Ridge$1.1M
- Robert SussmanSummit$645K
- Ronaldo GoHackensack$563K
- Deborah GossHackensack$558K
- Sabina HussainNew Brunswick$555K
- Manuel CunananMillville$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.